Furthermore, APS significantly ameliorated renal injury by decreasing the expression of inflammatory factors IL-1β, IL-6, and MCP-1 and inhibiting the activity of TLR4/NF-κB pathway in rats [142]. Here, NFKB1 is linked to autoimmune polyendocrinopathy.